Concepedia
Statistics
Publications
23
Citations
1.1K
H-Index
20
Active since
2004
Affiliations
Sunesis (United States)(Current)
Charles River Laboratories (United Kingdom)
Gene Therapy Laboratory
Emily J. Hanan is an author at Sunesis (United States) specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryPharmacotherapyBiochemistryDrug DevelopmentMedicinal ChemistryNatural SciencesCell SignalingDrug Resistance
Publications per year
2004–2022
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
Emily J. Hanan, Marie-Gabrielle Braun, Robert A. Heald et al. · Journal of Medicinal Chemistry · 2022 · 119 citations · Full text
Discovery of a potent and selective Aurora kinase inhibitor
Johan D. Oslob, M.J. Romanowski, Darin A. Allen et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 107 citations · Full text
Signaling Pathway, Receptor Tyrosine Kinase, Medicine +4
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye
Min Zhong, Thomas R. Gadek, Minna Bui et al. · ACS Medicinal Chemistry Letters · 2012 · 94 citations · Full text
Ocular Disease, Immunology, Immunologic Mechanism +17
Structure of the essential inner membrane lipopolysaccharide–PbgA complex
Thomas Clairfeuille, Kerry R. Buchholz, Qingling Li et al. · Nature · 2020 · 91 citations · Full text
Proteinlipid Interaction, Engineering, Membrane Biophysics +3
Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
Emily J. Hanan, Anne van Abbema, Kathy Barrett et al. · Journal of Medicinal Chemistry · 2012 · 89 citations · Full text
Lead Compounds, Drug Target, Chemoprevention Strategy +19
1–5 of 23